Shares of NeuroMetrix, Inc. (NURO) are climbing over 18 percent on Friday morning after the healthcare company announced steps to enhance shareholder value.
As part of the move, the company has appointed Joshua Horowitz as a new independent director for one year, and terminated its at-the-market equity facility it had entered into with Ladenburg Thalmann & Co., Inc.
Currently, NeuroMetrix's stock is moving up 18.40 percent, to $4.29 on the Nasdaq.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.